Cholesterol-lowering therapy after acute myocardial infarction in a low coronary risk population

被引:0
|
作者
Andrikopoulos, G
Richter, D
Zairis, M
Needham, E
Grammatopoulos, D
Foussas, S
Mattu, R
Stefanadis, C
Gialafos, J
Toutouzas, P
机构
[1] Hippokratio Gen Hosp, Dept Cardiac, Athens, Greece
[2] Tzanelon Hosp, Dept Cardiac, Pireaus, Greece
[3] Walsgrave Gen Hosp, Dept Cardiac, Coventry CV2 2DY, W Midlands, England
[4] Univ Warwick, Dept Biol Sci, Warwick, England
[5] Hippokratio Gen Hosp, State Cardiac Dept, Athens, Greece
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P3759
引用
收藏
页码:702 / 702
页数:1
相关论文
共 50 条
  • [31] New cholesterol lowering agent after myocardial infarction?
    Rostadmo, Martine
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2015, 135 (17) : 1548 - 1548
  • [32] Pharmacogenomics and pharmacogenetics of cholesterol-lowering therapy
    Schmitz, G
    Drobnik, W
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (04) : 581 - 589
  • [33] Pleiotropic Effects and Cholesterol-Lowering Therapy
    Shaw, Steven M.
    Fildes, James E.
    Yonan, Nizar
    Williams, Simon G.
    CARDIOLOGY, 2009, 112 (01) : 4 - 12
  • [34] Ten SNPs in genes within the cholesterol-lowering pathway modify the effectiveness of statins in reducing the risk of myocardial infarction
    Peters, W. M.
    Pett, H.
    Klungel, O. H.
    PHARMACOGENOMICS, 2012, 13 (01) : 18 - 18
  • [35] THE EFFECT OF CHOLESTEROL-LOWERING ON MYOCARDIAL-ISCHEMIA
    ANDREWS, TC
    SELWYN, AP
    GANZ, P
    NAIMI, C
    KADRO, W
    BARRY, J
    RABY, KE
    CIRCULATION, 1994, 90 (04) : 27 - 27
  • [36] Cholesterol-lowering treatment improves coronary microvascular dysfunction after PCI
    Manfrini, O
    Pizzi, C
    Morgagni, G
    Bugiardini, R
    CIRCULATION, 2002, 106 (19) : 703 - 703
  • [37] Cholesterol-lowering treatment improves coronary microvascular dysfunction after PTCA
    Manfrini, O
    Pizzi, C
    Gentile, M
    Morgagni, G
    Propato, N
    Bugiardini, R
    EUROPEAN HEART JOURNAL, 2001, 22 : 612 - 612
  • [38] Cholesterol-lowering therapy and the Australian Pharmaceutical Benefits Scheme: a population study
    Adams, Robert J.
    Appleton, Sarah
    Wilson, David H.
    Taylor, Anne W.
    Chittleborough, Catherine
    Gill, Tiffany
    Ruffin, Richard E.
    AUSTRALIAN HEALTH REVIEW, 2009, 33 (02) : 325 - 333
  • [39] Cholesterol absorption inhibition: A strategy for cholesterol-lowering therapy
    Miettinen, TA
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2001, 55 (10) : 710 - 716
  • [40] Lipid-lowering therapy after myocardial infarction: The Bavarian cholesterol screening project
    Richter, WO
    Schwandt, P
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07): : 603 - 604